THE D MAJOR GROUP for CVS CAREMARK
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues related to pharmacy delivery including S. 2615, The Increasing Competition in Pharmaceuticals Act; H.R. 34, The 21st Century Cures Act; and H.R. 244, The MAC Transparency Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Policy Analyst for Senate Republican Policy Committee |
| BRENDA REESE | Conference Coordinator for House Republican Conference |
Taxation/Internal Revenue Code TAX
Issues concerning comprehensive tax reform, including reducing the domestic corporate rate.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Policy Analyst for Senate Republican Policy Committee |
| BRENDA REESE | Conference Coordinator for House Republican Conference |
Health Issues HCR
Issues concerning health information technology innovation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Policy Analyst for Senate Republican Policy Committee |
| BRENDA REESE | Conference Coordinator for House Republican Conference |
Medicare/Medicaid MMM
Issues concerning the administration of the Medicare Part D prescription drug benefit. In addition, home infusion payment matters as contained in H.R. 34, The 21st Century Cures Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Policy Analyst for Senate Republican Policy Committee |
| BRENDA REESE | Conference Coordinator for House Republican Conference |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.